Shares of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL – Get Rating) have received a consensus recommendation of “Hold” from the eight ratings firms that are currently covering the firm, Marketbeat.com reports. Five research analysts have rated the stock with a hold rating and three have issued a buy rating on the company. The average 1 year price […]
StockNews.com assumed coverage on shares of Rigel Pharmaceuticals (NASDAQ:RIGL – Get Rating) in a research note published on Thursday morning. The firm issued a hold rating on the biotechnology company’s stock. A number of other research firms have also weighed in on RIGL. Piper Sandler reaffirmed a neutral rating and issued a $2.00 price objective […]
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL – Get Rating) has been given a consensus recommendation of “Hold” by the eight analysts that are currently covering the stock, Marketbeat Ratings reports. Five research analysts have rated the stock with a hold rating and three have given a buy rating to the company. The average 12 month price target […]
StockNews.com cut shares of Rigel Pharmaceuticals (NASDAQ:RIGL – Get Rating) from a buy rating to a hold rating in a report issued on Friday morning. RIGL has been the topic of several other research reports. HC Wainwright reiterated a buy rating and issued a $15.00 price target on shares of Rigel Pharmaceuticals in a report […]
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL – Get Rating) – Equities research analysts at B. Riley increased their FY2023 earnings per share estimates for shares of Rigel Pharmaceuticals in a research report issued to clients and investors on Wednesday, May 3rd. B. Riley analyst K. Patel now forecasts that the biotechnology company will earn ($0.26) per share […]